Skip to content

Scholar Rock SRRK Operating margin

Discontinued — last reported Q1 '22

Operating margin at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
1.6%-38.7pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
44.8%+1.6pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-90.5%-41.2pp
Arrowhead Research logo
Arrowhead ResearchARWR
-35.7%+63.6pp
Cytokinetics logo
CytokineticsCYTK
-605.1%-268pp
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-192.4%-205pp

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Calculated from Scholar Rock’s reported figures.

Based on trailing twelve months.

The official record: Scholar Rock’s 10-Q, filed May 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's operating margin?
Scholar Rock (SRRK) reported operating margin of -231.8% in Q1 2022.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.